Attilio Orazi, MD

Attilio Orazi, MD

Texas Tech University

H-index: 73

North America-United States

About Attilio Orazi, MD

Attilio Orazi, MD, With an exceptional h-index of 73 and a recent h-index of 45 (since 2020), a distinguished researcher at Texas Tech University, specializes in the field of Pathology, Hematopathology.

His recent articles reflect a diverse array of research interests and contributions to the field:

Mast cell cytomorphology and treatment outcome in mast cell leukemia

Chronic neutrophilic leukemia and atypical chronic myeloid leukemia: 2024 update on diagnosis, genetics, risk stratification, and management

Predictors of clinical outcome in myeloproliferative neoplasm, unclassifiable: A Bone Marrow Pathology Group study

Incidental discovery of KIT‐mutated mastocytoma in a colon polyp

Granularity in disease classification impacts survival prediction in advanced systemic mastocytosis: A single institution study of 329 informative cases

Clinicopathologic characteristics of myeloproliferative neoplasms with JAK2 exon 12 mutation

Guide to the Diagnosis of Myeloid Neoplasms: A Bone Marrow Pathology Group Approach

The International Consensus Classification of myelodysplastic syndromes and related entities

Attilio Orazi, MD Information

University

Position

Texas Tech University Health Sciences Center

Citations(all)

33480

Citations(since 2020)

16615

Cited By

23482

hIndex(all)

73

hIndex(since 2020)

45

i10Index(all)

252

i10Index(since 2020)

161

Email

University Profile Page

Texas Tech University

Google Scholar

View Google Scholar Profile

Attilio Orazi, MD Skills & Research Interests

Pathology

Hematopathology

Top articles of Attilio Orazi, MD

Title

Journal

Author(s)

Publication Date

Mast cell cytomorphology and treatment outcome in mast cell leukemia

American journal of hematology

Ayalew Tefferi

Animesh Pardanani

Aref Al-Kali

Hassan Alkhateeb

Kristen McCullough

...

2024/1

Chronic neutrophilic leukemia and atypical chronic myeloid leukemia: 2024 update on diagnosis, genetics, risk stratification, and management

Natasha Szuber

Attilio Orazi

Ayalew Tefferi

2024/4/21

Predictors of clinical outcome in myeloproliferative neoplasm, unclassifiable: A Bone Marrow Pathology Group study

American Journal of Clinical Pathology

Genevieve M Crane

Julia T Geyer

Beenu Thakral

Sa A Wang

Geoffrey D Wool

...

2024/4/10

Incidental discovery of KIT‐mutated mastocytoma in a colon polyp

American journal of hematology

Naseema Gangat

Ellen McPhail

Kaaren Reichard

Attilio Orazi

Animesh Pardanani

...

2024/1/25

Granularity in disease classification impacts survival prediction in advanced systemic mastocytosis: A single institution study of 329 informative cases

American journal of hematology

Ayalew Tefferi

Maymona Abdelmagid

Aref Al‐Kali

Mrinal Patnaik

William J Hogan

...

2024/1

Clinicopathologic characteristics of myeloproliferative neoplasms with JAK2 exon 12 mutation

Leukemia Research

Kran Suknuntha

Julia T Geyer

Keyur Pravinchandra Patel

Olga K Weinberg

Heesun J Rogers

...

2023/4/1

Guide to the Diagnosis of Myeloid Neoplasms: A Bone Marrow Pathology Group Approach

American Journal of Clinical Pathology

Kathryn Foucar

Adam Bagg

Carlos E Bueso-Ramos

Tracy George

Robert P Hasserjian

...

2023/10/1

The International Consensus Classification of myelodysplastic syndromes and related entities

Robert P Hasserjian

Attilio Orazi

Alberto Orfao

Maria Rozman

Sa A Wang

2023/1

Systemic mastocytosis: a (slightly) simplified diagnostic approach

Pathology

Attilio Orazi

2023/2/1

TP53 mutations and variant allele frequency in myelodysplastic syndromes with del (5q): A Mayo-Moffitt study of 156 informative cases

American journal of hematology

Farah Fleti

Onyee Chan

Amritpal Singh

Maymona G Abdelmagid

Aref Al-Kali

...

2023/4

Reappraisal of mast cell leukemia based on a single institution review of 16 cases: Mast cell morphology determines clinical outcome.

American journal of hematology

Animesh Pardanani

Ayalew Tefferi

Aref Al-Kali

Mrinal Patnaik

William J Hogan

...

2023/9/9

Multi-Hit TP53 Mutations in Myeloid Neoplasms: Prognostic Impact of Morphologic Subtype Designation and Variant Allele Frequency

Blood

Maymona Abdelmagid

Kaaren K Reichard

Omer Karrar

Rong He

Patricia Greipp

...

2023/11/28

The International Consensus Classification of acute myeloid leukemia

Olga K Weinberg

Anna Porwit

Attilio Orazi

Robert P Hasserjian

Kathryn Foucar

...

2023/1

Clinicopathologic and molecular analysis of normal karyotype therapy-related and de novo acute myeloid leukemia: a multi-institutional study by the bone marrow pathology group

JCO Precision Oncology

Miguel D Cantu

Rashmi Kanagal-Shamanna

Sa A Wang

Tapan Kadia

Carlos E Bueso-Ramos

...

2023/1

What’s New in the Classification, Diagnosis and Therapy of Myeloid Leukemias

Marco Pizzi

Carmela Gurrieri

Attilio Orazi

2023/3/29

The international consensus classification of eosinophilic disorders and systemic mastocytosis

Sa A Wang

Attilio Orazi

Jason Gotlib

Andreas Reiter

Alexandar Tzankov

...

2023/8

TP53 variant allele frequency and therapy-related setting independently predict survival in myelodysplastic syndromes with del (5q)

Blood

Farah Fleti

Onyee Chan

Najla H Al Ali

Aref Al-Kali

Kebede Begna

...

2023/11/28

The international consensus classification of mastocytosis and related entities

Roos J Leguit

Sa A Wang

Tracy I George

Alexandar Tzankov

Attilio Orazi

2023/1

International Consensus Classification of myeloid and lymphoid neoplasms: myeloproliferative neoplasms

Blood, The Journal of the American Society of Hematology

Daniel A Arber

Attilio Orazi

Robert P Hasserjian

Michael J Borowitz

Katherine R Calvo

...

2022/9/15

Triple-negative primary myelofibrosis: a bone marrow pathology group study

Modern Pathology

Yahya A Al-Ghamdi

Jonathan Lake

Adam Bagg

Beenu Thakral

Sa A Wang

...

2023/3/1

See List of Professors in Attilio Orazi, MD University(Texas Tech University)